MKSI Stock Analysis: MKS Instruments | NASDAQ
Scientific & Technical Instruments | NASDAQ, USA | Market Cap: 13.678m USD | 12M Return: 56% | US55306N1046 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 305M
EPS Trend: 96.4%
Qual. Beats: 2
Rev. Trend: 71.6%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
MKS Inc. (NASDAQ: MKSI) is a provider of foundational technology solutions serving semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company is organized into three operating segments: the Vacuum Solutions Division (VSD), which offers pressure and flow measurement, gas delivery, gas composition analysis, and related control technologies; the Photonics Solutions Division (PSD), which supplies lasers, photonics, optics, precision motion control, and vibration control products; and the Material Solutions Division (MSD), which develops advanced surface modification, electroless and electrolytic plating, and surface finishing technologies for chemistry and equipment markets. MKS sells through direct sales, independent distributors, sales representatives, and online product catalogs, and maintains operations across the United States, China, South Korea, Japan, Taiwan, Singapore, and other international markets.
The company was incorporated in 1961 and is headquartered in Andover, Massachusetts. It was renamed from MKS Instruments, Inc. to MKS Inc. in May 2025. As a constituent of the Semiconductor Materials & Equipment sub-industry within the Information Technology sector, MKS operates in a market characterized by cyclical demand tied to global wafer fab equipment (WFE) spending, with its gas delivery, vacuum, and photonics technologies widely embedded in chip fabrication and adjacent advanced manufacturing processes.
- Semiconductor capital equipment demand from AI chip fab buildouts lifts VSD and PSD orders
- Margin pressure persists from inventory correction and customer utilization headwinds
- China revenue concentration exposes MKSI to export controls and geopolitical tariffs
| Net Income: 440.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.87 > 1.0 |
| NWC/Revenue: 8.05% < 20% (prev 44.18%; Δ -36.13% < -1%) |
| CFO/TA 0.07 > 3% & CFO 635.0m > Net Income 440.0m |
| Net Debt (3.82b) to EBITDA (1.02b): 3.75 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.7m) vs 12m ago 7.86% < -2% |
| Gross Margin: 44.12% > 18% (prev 47.34%; Δ -3.22% > 0.5%) |
| Asset Turnover: 48.93% > 50% (prev 42.36%; Δ 6.57% > 0%) |
| Interest Coverage Ratio: 3.53 > 6 (EBIT TTM 675.0m / Interest Expense TTM 191.0m) |
| A: 0.04 (Total Current Assets 2.77b - Total Current Liabilities 2.42b) / Total Assets 8.94b |
| B: 0.10 (Retained Earnings 936.0m / Total Assets 8.94b) |
| C: 0.08 (EBIT TTM 675.0m / Avg Total Assets 8.88b) |
| D: 0.50 (Book Value of Equity 2.99b / Total Liabilities 5.95b) |
| Altman-Z'' = 1.64 = BB |
| DSRI: 1.10 (Receivables 830.0m/649.0m, Revenue 4.35b/3.74b) |
| GMI: 1.07 (GM 47.34% / 44.12%) |
| AQI: 0.96 (AQ_t 0.57 / AQ_t-1 0.60) |
| SGI: 1.16 (Revenue 4.35b / 3.74b) |
| TATA: -0.02 (NI 440.0m - CFO 635.0m) / TA 8.94b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of October 29, 2026, the stock is trading at USD 218.24 with a total of 970,346 shares traded. Over the past week, the price has changed by +0.99%, over one month by -15.54%, over three months by -23.44% and over the past year by +56.00%.
Current recommended Stop Loss: 196.30 (which is 10.1% or 1.8 ATR below the current price).
MKS Instruments has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy MKSI.
- StrongBuy: 9
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 406.9 | 86.5% |
P/E Trailing = 32.159
P/E Forward = 10.3627
P/S = 3.1465
P/B = 4.4479
P/EG = 1.3236
Revenue TTM = 4.35b USD
EBIT TTM = 675.0m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 2.54b USD (from longTermDebt, last quarter)
Short Term Debt = 1.40b USD (from shortTermDebt, last quarter)
Debt = 4.43b USD (from shortLongTermDebtTotal, last quarter) + Leases 243.0m
Net Debt = 3.82b USD (calculated: Debt 4.43b - CCE 611.0m)
Enterprise Value = 17.5b USD (13.7b + Debt 4.43b - CCE 611.0m)
Interest Coverage Ratio = 3.53 (Ebit TTM 675.0m / Interest Expense TTM 191.0m)
EV/FCF = 38.54x (Enterprise Value 17.5b / FCF TTM 454.0m)
FCF Yield = 2.59% (FCF TTM 454.0m / Enterprise Value 17.5b)
FCF Margin = 10.44% (FCF TTM 454.0m / Revenue TTM 4.35b)
Net Margin = 10.12% (Net Income TTM 440.0m / Revenue TTM 4.35b)
Gross Margin = 44.12% ((Revenue TTM 4.35b - Cost of Revenue TTM 2.43b) / Revenue TTM)
Gross Margin QoQ = 47.68% (prev 41.19%)
Tobins Q-Ratio = 1.96 (Enterprise Value 17.5b / Total Assets 8.94b)
Interest Expense / Debt = 4.31% (Interest Expense 191.0m / Debt 4.43b)
Taxrate = 9.84% (48.0m / 488.0m)
NOPAT = 608.6m (EBIT 675.0m * (1 - 9.84%))
Current Ratio = 1.14 (Total Current Assets 2.77b / Total Current Liabilities 2.42b)
Debt / Equity = 1.48 (Debt 4.43b / totalStockholderEquity, last quarter 2.99b)
Debt / EBITDA = 3.75 (Net Debt 3.82b / EBITDA 1.02b)
Debt / FCF = 8.41 (Net Debt 3.82b / FCF TTM 454.0m)
Total Stockholder Equity = 2.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.95% (Net Income 440.0m / Total Assets 8.94b)
RoE = 15.83% (Net Income TTM 440.0m / Total Stockholder Equity 2.78b)
RoCE = 12.68% (EBIT 675.0m / Capital Employed (Equity 2.78b + L.T.Debt 2.54b))
RoIC = 7.91% (NOPAT 608.6m / Invested Capital 7.70b)
WACC = 13.53% (E(13.7b)/V(18.1b) * Re(16.65%) + D(4.43b)/V(18.1b) * Rd(4.31%) * (1-Tc(0.10)))
Discount Rate = 16.65% (= CAPM, Blume Beta Adj.) -> capped to 12.54%
Shares (quarterly) Correlation: 73.51 | Cagr: 3.42%
[DCF] Terminal Value 56.75% ; FCFF base≈482.4m ; Y1≈429.1m ; Y5≈356.8m
[DCF] Fair Price = N/A (negative equity: EV 3.10b - Net Debt 3.82b = -719.3m; debt exceeds intrinsic value)
EPS Correlation: 96.36 | EPS CAGR: 29.60% | SUE: 2.55 | # QB: 2
Revenue Correlation: 71.59 | Revenue CAGR: 4.94% | SUE: 3.90 | # QB: 2
EPS current Quarter (2026-09-30): EPS=3.63 | Chg30d=+0.00% | Revisions=+25% | Analysts=13
EPS current Year (2026-12-31): EPS=13.15 | Chg30d=+0.06% | Revisions=+25% | GrowthEPS=+66.9% | GrowthRev=+29.3%
EPS next Year (2027-12-31): EPS=17.62 | Chg30d=+0.39% | Revisions=+40% | GrowthEPS=+33.9% | GrowthRev=+20.5%
[Analyst] Revisions Ratio: +57% (up=4, down=0)